Furthermore, we also found that a high level of SOD was an independent protective factor for HM, even after adjustment for other relevant predictors including mAlb, α1-MG and Scr, suggesting that SOD might be a potential therapeutic target for HM in patients with hypertension. The gene discussed is SOD1; the disease is Hypertension.